期刊
NATURE REVIEWS MOLECULAR CELL BIOLOGY
卷 20, 期 10, 页码 569-570出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41580-019-0147-x
关键词
-
类别
Epigenetic regulatory enzymes are generally considered innovative targets for cancer therapy and several histone methyltransferase inhibitors are currently being evaluated in phase I and phase II clinical trials. In this commentary, we discuss the need for better functional understanding of histone methyltransferases and especially of their potential non-histone substrates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据